|Articles|August 23, 2019
CRISPR-edited EML4-ALK Isogenic Cell Line
Author(s)ATCC
Cancer researchers are challenged by the lack of precise disease models. Genome editing was used to create an isogenic lung cancer cell line that was tested for drug sensitivity.
Related Content
Sponsored Content
Trending on Pharmaceutical Technology
1
Brent Wilhelm on Why Drug Shortages Persist Despite Available Inventory
2
FDA Activity Round Up – July 2026
3
Can Governance-by-Design Make AI Compliant in Pharma? (Part II)
4
From Predictions to Reality: Mike Stenberg Assesses Pharma Manufacturing's First Half of 2026
5